Your browser doesn't support javascript.
loading
Methodological advances in the discovery of novel neuroblastoma therapeutics.
Segura, Miguel F; Soriano, Aroa; Roma, Josep; Piskareva, Olga; Jiménez, Carlos; Boloix, Ariadna; Fletcher, Jamie I; Haber, Michelle; Gray, Juliet C; Cerdá-Alberich, Leonor; Martínez de Las Heras, Blanca; Cañete, Adela; Gallego, Soledad; Moreno, Lucas.
Afiliação
  • Segura MF; Pediatric Oncology and Hematology Department, Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona. Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Soriano A; Pediatric Oncology and Hematology Department, Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona. Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Roma J; Pediatric Oncology and Hematology Department, Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona. Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Piskareva O; Cancer Bioengineering Group, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Jiménez C; Department of Anatomy and Regenerative Medicine, Advanced Materials and Bioengineering Research Centre (AMBER), RCSI and TCD, Dublin, Ireland.
  • Boloix A; National Children's Research Centre, OLCHC, Dublin, Ireland School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Fletcher JI; Pediatric Oncology and Hematology Department, Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona. Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Haber M; Pediatric Oncology and Hematology Department, Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona. Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Gray JC; Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW Sydney, Kensington, Australia.
  • Cerdá-Alberich L; Children's Cancer Institute Australia, Lowy Cancer Research Centre, UNSW Sydney, Kensington, Australia.
  • Martínez de Las Heras B; Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, UK.
  • Cañete A; Grupo de Investigación Biomédica En Imagen, Instituto de Investigación Sanitaria La Fe, Spain.
  • Gallego S; Unidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Spain.
  • Moreno L; Unidad de Oncohematología Pediátrica, Hospital Universitario y Politécnico La Fe, Spain.
Expert Opin Drug Discov ; 17(2): 167-179, 2022 02.
Article em En | MEDLINE | ID: mdl-34807782
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Neuroblastoma Limite: Child / Humans Idioma: En Revista: Expert Opin Drug Discov Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Neuroblastoma Limite: Child / Humans Idioma: En Revista: Expert Opin Drug Discov Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido